| Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha, M Mota, M Pun, ... Cancer discovery 13 (11), 2370-2393, 2023 | 66 | 2023 |
| Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma E Cantor, K Wierzbicki, RS Tarapore, K Ravi, C Thomas, R Cartaxo, ... Neuro-oncology 24 (8), 1366-1374, 2022 | 63 | 2022 |
| Patient perceptions of SARS-CoV-2 exposure risk and association with continuity of ophthalmic care A Lindeke-Myers, PYC Zhao, BI Meyer, EA Liu, DA Levine, OM Bennett, ... JAMA ophthalmology 139 (5), 508-515, 2021 | 49 | 2021 |
| Propagating humanized BLT mice for the study of human immunology and immunotherapy DJ Smith, LJ Lin, H Moon, AT Pham, X Wang, S Liu, S Ji, V Rezek, ... Stem cells and development 25 (24), 1863-1873, 2016 | 49 | 2016 |
| Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells DJ Smith, S Liu, S Ji, B Li, J McLaughlin, D Cheng, ON Witte, L Yang Proceedings of the National Academy of Sciences 112 (5), 1523-1528, 2015 | 45 | 2015 |
| Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations HJ Roberts, S Ji, A Picca, M Sanson, M Garcia, M Snuderl, U Schüller, ... Acta Neuropathologica 146 (6), 849-852, 2023 | 16 | 2023 |
| Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine K Schwark, D Messinger, JR Cummings, J Bradin, A Kawakibi, CM Babila, ... Frontiers in oncology 12, 922928, 2022 | 11 | 2022 |
| A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experience CJ Evans, JM Olson, BC Mondal, P Kandimalla, A Abbasi, ... G3 11 (1), jkaa028, 2021 | 11 | 2021 |
| Analysis of female participant representation in registered oncology clinical trials in the United States from 2008 to 2020 ND Perera, TR Bellomo, WM Schmidt, HK Litt, M Shyu, MKA Stavins, ... The oncologist 28 (6), 510-519, 2023 | 10 | 2023 |
| Increased intraoperative faculty entrustment and resident entrustability does not compromise patient outcomes after general surgery procedures AM Williams, M Karmakar, J Thompson-Burdine, N Matusko, S Ji, ... Annals of Surgery 275 (2), e366-e374, 2022 | 9 | 2022 |
| A road map for the treatment of pediatric diffuse midline glioma C Koschmann, WN Al-Holou, MM Alonso, J Anastas, P Bandopadhayay, ... Cancer cell 42 (1), 1-5, 2024 | 6 | 2024 |
| Association of intraoperative entrustment with clinical competency amongst general surgery residents S Ji, C Hwang, M Karmakar, N Matusko, J Thompson-Burdine, ... The American Journal of Surgery 219 (2), 245-252, 2020 | 4 | 2020 |
| Proximogram—A multi-omics network-based framework to capture tissue heterogeneity integrating single-cell omics and spatial profiling SN Krishnan, S Ji, AM Elhossiny, A Rao, TL Frankel, A Rao Computers in Biology and Medicine 182, 109082, 2024 | 1 | 2024 |
| Female participation in US oncology clinical trials registered on ClinicalTrials. gov from 2008 to 2020. ND Perera, TR Bellomo, HK Litt, S Fattahi, A Bell, MKA Stavins, M Saleki, ... Journal of Clinical Oncology 39 (28_suppl), 85-85, 2021 | 1 | 2021 |
| TMOD-29. BETA INTEGRINS REGULATE MITOCHONDRIALLY-MEDIATED CELL MIGRATION IN H3K27M-DIFFUSE MIDLINE GLIOMA R Cartaxo, E Nieblas-Bedolla, M Niculcea, S Natarajan, T Adam, ... Neuro-Oncology 26 (Supplement_8), viii325-viii326, 2024 | | 2024 |
| TMET-16. GABA PRODUCTION INDUCED BY IMIPRIDONES IS A TARGETABLE AND IMAGEABLE METABOLIC ALTERATION IN DIFFUSE MIDLINE GLIOMAS G Batsios, S Udutha, C Taglang, AM Gillespie, B Lau, S Ji, T Phoenix, ... Neuro-Oncology 26 (Supplement_8), viii291-viii291, 2024 | | 2024 |
| HGG-52. MULTI-INTEGRIN TARGETING EFFECTIVELY SUPPRESSES DIFFUSE MIDLINE GLIOMA MIGRATION R Cartaxo, E Nieblas-Bedolla, M Niculcea, M Miclea, K Schwark, S Ji, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| MDB-78. ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS D Dang, J McKolay, K Smith, P Panwalkar, S Sweha, SK Natarajan, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Abstract B001: Glioblastoma evolution and resistance is mediated by a shift in cell state and tumor microenvironmental interactions S Shankar, V Ravikumar, A Tripathy, S Ji, J Loper, Z Hassan, Z Fehmi, ... Cancer Research 84 (5_Supplement_1), B001-B001, 2024 | | 2024 |
| GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas G Batsios, S Udutha, C Taglang, AM Gillespie, B Lau, S Ji, T Phoenix, ... bioRxiv, 2024.06. 07.597982, 2024 | | 2024 |
